Results for “DIT Holdings LLC”

From: Sent: To: Subject: Weingarten, Reid 7/4/2017 5:57:07 PM jeffrey E. [[email protected]] Re: The new iterations of Ghislaine Maxwell Importance: High Too down...give me another day Sent from my BlackBerry 10 smartphone. From: Jeffrey E. Sent: Tuesday, July 4, 2017 12:53 P...

From: Faith Kates Sent: 12/17/2010 1:13:39 PM To: Jeffrey Epstein [[email protected]] Subject: RE: Importance: — High Neither very funny...always ask for the 3 minute version but most of the girls you Know haven't spoken for a total of 30 minutes in all the time you knew t...

Unlike the check-the-box rules, there are conflicting views regarding the treatment of a grantor trust as a DRE. While the plain language of the Code's grantor trust rules appears to imply that a wholly grantor trust (i.¢., a trust that is deemed to be entirely owned by a single...

…lly address the treatment of disregarded entities (also called “fiscally transparent” entities by some treaties). In addition to some countries treating DREs differently than the U.S., the Code contains some provisions that create special rules for certain DREs (or “fiscally tra...

Or > A “Bw Plan fon on RO RUBICON . . ORGANICS Rubicon Organics Bellingham, Washington www.rubiconorganics.com Rubicon Organics is a licensed cannabis culti- vator specializing in the growing, processing, packaging and marketing of cannabis. The com- pany is developing greenho...

Or LA “a Pr cre Confident Cannabis Palo Alto, California www.confidentcannabis.com Confident Cannabis is a cannabis lab-testing and analytics company. The company allows users to view the results of their product testing and analytics in an online platform. Its technol- ogy ca...

…lassified as a Schedule I controlled substance under the Controlled Substances Act in the United States. In this new edition, we introduce an outlook on global cannabis markets, analyze capital markets for cannabis companies and present updated market estimates. We also expand...

A > LA RELL ITAL Cannabis Investment Report | December 2017 Cannabinoid a class of chemical compounds present in cannabis that act on cannabinoid receptors in cells in the human nervous and immune systems Cannabinol (CBN) a cannabinoid derived from THC degradation; shown to p...

A =a ELL TAL Cannabis Investment Report | December 2017 Ackrell Capital Cannabis Team Mike Ackrell founded Ackrell Capital in 2003. Previously, Mr. Ackrell was the Head of ABN AMRO’s U.S. Technology Investment Banking Group and the Head of Invest- ment Banking at WR Hambrecht+...

THANKS & TEAM ESRI GE WILLIAM R. HEARST III SCROLLMOTION JOHN HALLORAN ASSOCIATES LLC @RADICAL.MEDIA FORA.TV HARPERVISION DOTSUB KEN HERTZ MAGGIE XIAO (CHINA) ADAM BLY PAUL SOULELLIS INTERNATIONAL DATA GROUP INSTITUTE FOR INTERNATIONAL RESEARCH FLIPBOARD CHAPPELLET VINE...

…fied dividends and the new tax rates 2003-11 06/06/03 JGTRRA: lower rates, qualified dividends, increased child tax credit; marriage penalty 2003-10 relief; increased AMT exemption; chart with phase-outs of the AMT exemption amounts 05/16/03 Jobs and growth bill; trust’s invest...

3. USE OF PROCEEDS The proceeds of this offering will be used: (i} to expand operations, including through strategic acquisitions in the U.S. and internationally, (ii) to develop new products and services, {iii} to repay, in whole or in part, $150 million of existing debt plus a...

…s (currently few in number, but growing), and (v) strategic investors. However, because of the legal considerations, traditional institutional investors—most notably the venture capital and private equity communities— continue to be mostly absent from the market. As with most ea...

…an stock markets. As stated previously, many cannabis-related companies are traded on more than one market to attract additional investors and facilitate trading in multiple jurisdictions. For example, most companies traded on the Canadian markets are also traded on the OTC. Sum...

…een constrained due to the lack of access to purely recreational consumers and the sometimes-narrow scope of medical conditions that qualify a patient to access medical cannabis. We estimate that the 2017 U.S. state-legal cannabis market was $8.0 billion, with more than four mil...